Decrease the Burden of Oncology Clinical Trials with Patient-Friendly Technologies, Upcoming Webinar Hosted by Xtalks
In this free webinar, a former oncology clinical trial participant and cancer survivor—who is also a pharmaceutical R&D leader—will share some of her experiences as a clinical trial participant, including the impact of technology. She and other panelists will examine patient technologies... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 3, 2024 Category: Pharmaceuticals Tags: FVT TRI Source Type: news
Hoag launches Pylarify PET prostate cancer trial
Hoag healthcare system in Orange County, CA, has launched a clinical trial to assess the prostate cancer PET imaging radiotracer Pylarify in patients newly diagnosed with intermediate disease.
Currently, the radiotracer is approved in the U.S. for diagnosed prostate cancer patients to identify suspected metastasis or recurrence of the disease. The trial will use Pylarify with whole-body PET/CT scans in men with favorable intermediate prostate cancer, including Gleason Score 3+4 tumors, Hoag said.
The phase IV open-label multicenter trial will ultimately assess the safety and accuracy of the approach in an estimated 274 p...
Source: AuntMinnie.com Headlines - April 3, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
SA cancer research company gets new majority investor and CEO
A global firm plans to infuse new capital to expand the clinical trials company's work and international presence. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 2, 2024 Category: Biotechnology Authors: W. Scott Bailey Source Type: news
Clinical and Radiographic Failure of Non-surgical Endodontic Treatment and Retreatment Using Single-cone Technique with Calcium Silicate-Based Sealers: A Systematic Review and Meta-Analysis
ConclusionsThe overall results of this systematic review and meta-analysis demonstrate that the
SC obturation technique with CSBC sealer provides similar results compared to other
obturation materials and techniques in facilitating the healing of apical periodontitis. (Source: Dental Technology Blog)
Source: Dental Technology Blog - April 2, 2024 Category: Dentistry Source Type: news
Voiant's Commitment to Quality Affirmed by FDA Inspection with No Findings Raised
Voiant, a leader in clinical trial imaging solutions, is proud to announce the successful completion of an inspection conducted by the U.S. Food and Drug Administration (FDA). WALTHAM, Mass., April 2, 2024 /PRNewswire-PRWeb/ -- Voiant, a leader in clinical trial imaging solutions, is... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 2, 2024 Category: Pharmaceuticals Tags: TRI Source Type: news
New Trials in Prostate Cancer: Could Your Patient Benefit? New Trials in Prostate Cancer: Could Your Patient Benefit?
Perhaps one of your patients could benefit from a clinical trial that has recently opened in prostate cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 2, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Extra Measures to Secure Kids' Peripheral IV Catheters Cuts Failures
(MedPage Today) -- Peripheral intravenous catheters (PIVCs) secured with integrated securement dressings and tissue adhesive failed significantly less than those with standard-of-care bordered polyurethane, a randomized clinical trial of 383 kids... (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - April 1, 2024 Category: Pediatrics Source Type: news
Are Muscle-Building Supplements a Good Idea?
Want to put on muscle? Who wouldn’t: It keeps you strong enough to do the things you love now, and it’s a great investment for later, since muscle improves bone mineral density and mobility as you age. People with more muscle mass have better outcomes when they’re sick, and quicker recoveries.
It’s hard not to be tempted by the powders, protein bars, and shakes promising to help. Whey, creatine, and branched-chain amino acids (BCAAs) are among the most popular of these. But what do they actually do, and who (if anyone) should take them?
[time-brightcove not-tgx=”true”]
Star...
Source: TIME: Health - April 1, 2024 Category: Consumer Health News Authors: Donavyn Coffey Tags: Uncategorized Evergreen freelance healthscienceclimate Source Type: news
Efficacy of a stannous fluoride dentifrice for relieving dentinal hypersensitivity in Chinese population: an 8-week randomized clinical trial
ConclusionsAll
groups demonstrated statistically significant improvements in Schiff
score, tactile threshold and OHRQoL. However, due to a possible placebo
effect in the negative control, there were no statistically significant
differences between the dentifrices.Clinical relevanceThis study adds to the growing research exploring why the placebo effect is a common phenomenon in DH studies. (Source: Dental Technology Blog)
Source: Dental Technology Blog - April 1, 2024 Category: Dentistry Source Type: news
Xtalks Announces its Life Science Webinar Calendar for April 2024
Upcoming free, educational webinars from Xtalks will feature topics on clinical trials, commercialization & HEOR, drug discovery & development, food, healthcare, laboratory technology, medical device, patient recruitment & retention, pharma manufacturing & supply chain and pharmaceutical... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 1, 2024 Category: Pharmaceuticals Tags: PDT Source Type: news
Study documents safety, improvements from stem cell therapy after spinal cord injury
ROCHESTER, Minn. — A Mayo Clinic study shows stem cells derived from patients' own fat are safe and may improve sensation and movement after traumatic spinal cord injuries. The findings from the phase 1 clinical trial appear in Nature Communications. The results of this early research offer insights on the potenti al of cell therapy for people living with spinal cord injuries and paralysis for whom options to improve function are extremely limited. In the study… (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - April 1, 2024 Category: Research Source Type: news
Uber, Axon Lead Five Stocks Near Buy Points
and Taser-maker Axon Enterprise (AXON) lead this weekend's watch list of five stocks near buy points. They're joined by Swiss athletic shoemaker On Holding (ONON), homebuilder M/I Homes (MHO) and Medpace Holdings (MEDP), which conducts clinical trials for biotech firms. The list features three…#taser #axonenterprise #axon #medpaceholdings #medp #ibdstockcheckup #ibdleaderboard #ibdlongtermleaders #truist #youssefsquali (Source: Reuters: Health)
Source: Reuters: Health - March 31, 2024 Category: Consumer Health News Source Type: news
AI-based Clinical Trials Solution Provider Market Report 2024-2034, Featuring CONSILX, AiCure, Unlearn.AI, Trials.Ai, Intelligencia, Symphony AI, GNS Healthcare, Verily, BioSymetrics & amp; BioAge Labs
DUBLIN, March 29, 2024 /PRNewswire/ -- The "Global AI-based Clinical Trials Solution Provider Market Analysis & Forecast to 2024-2034: Market By Clinical Trial Phase; By Therapeutic Application; By End-user; and By Region" report has been added to ResearchAndMarkets.com's offering. The... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 30, 2024 Category: Pharmaceuticals Tags: MRR Source Type: news
Genentech makes diversity, inclusion gains toward 2025 goals
The DEI report is far-reaching, covering the 10,000-employee biotech companies efforts in the workplace, among suppliers and in clinical trials. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 29, 2024 Category: Biotechnology Authors: Ron Leuty Source Type: news
Labcorp to pay $237.5M to acquire assets of BioReference Health's diagnostics business
Labcorp, the Burlington-based laboratory services company, has made five acquisitions since spinning off its clinical trials business last July. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 29, 2024 Category: Pharmaceuticals Authors: Daniel Finnegan Source Type: news
